120 related articles for article (PubMed ID: 1386354)
1. Identification of anti-CD3 antibodies that do not modulate antigen but induce mitogenesis and block the mixed lymphocyte reaction.
Rao PE; Newman W; Meyer E; Fahmy B; Talle MA; Fanning VA
Hum Immunol; 1992 Apr; 33(4):275-83. PubMed ID: 1386354
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
[TBL] [Abstract][Full Text] [Related]
3. OKT3E, an anti-CD3 antibody that does not elicit side effects or antiidiotype responses in chimpanzees.
Rao PE; Olini G; Kille J; Muchmore E; Talle MA; Brake G; Rudnick SA
Transplantation; 1991 Oct; 52(4):691-7. PubMed ID: 1718067
[TBL] [Abstract][Full Text] [Related]
4. Murine monoclonal IgG antibodies: differences in their IgG isotypes can affect the antibody effector activity when using human cells.
Lobo PI; Patel HC
Immunol Cell Biol; 1997 Jun; 75(3):267-74. PubMed ID: 9243292
[TBL] [Abstract][Full Text] [Related]
5. The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation.
Frenken LA; Koene RA; Tax WJ
Transplantation; 1991 Apr; 51(4):881-7. PubMed ID: 1826571
[TBL] [Abstract][Full Text] [Related]
6. Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.
Carreno M; Fuller L; Zucker K; Yang WC; Burke G; Nery J; Gomez C; Esquenazi V; Miller J
Hum Immunol; 1992 Apr; 33(4):249-58. PubMed ID: 1386353
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
8. Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals.
Schwinzer R; Sommermeyer H; Schlitt HJ; Schmidt RE; Wonigeit K
Cell Immunol; 1991 Sep; 136(2):318-28. PubMed ID: 1714794
[TBL] [Abstract][Full Text] [Related]
9. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
10. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.
Romani N; Inaba K; Puré E; Crowley M; Witmer-Pack M; Steinman RM
J Exp Med; 1989 Mar; 169(3):1153-68. PubMed ID: 2522496
[TBL] [Abstract][Full Text] [Related]
11. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
12. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine effect on anti-CD3 monoclonal antibody-stimulated mitogenesis, phorbol ester comitogenesis, and PGE2 production.
McMillen MA; Kharma B; Fuortes M; Schaefer HC; McGowan EA; Baumgarten WK; Hoover EM
J Surg Res; 1991 Jul; 51(1):66-71. PubMed ID: 1829779
[TBL] [Abstract][Full Text] [Related]
14. Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies.
Parren PW; Geerts ME; Boeije LC; Aarden LA
Res Immunol; 1991; 142(9):749-63. PubMed ID: 1839077
[TBL] [Abstract][Full Text] [Related]
15. Dichotomous effect of monocyte Fc receptor interaction on anti-CD3-induced immunoglobulin synthesis.
Wyss T; Bettens F; Walker C; Pichler WJ
Cell Immunol; 1990 Mar; 126(1):91-105. PubMed ID: 2137378
[TBL] [Abstract][Full Text] [Related]
16. Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen.
Anasetti C; Tan P; Hansen JA; Martin PJ
J Exp Med; 1990 Dec; 172(6):1691-700. PubMed ID: 2147949
[TBL] [Abstract][Full Text] [Related]
17. CD3.TCR1, a human CD3 epitope expressed on viable gamma/delta lymphocytes exclusively.
Miossec C; Genevee C; Hercend T; Jitsukawa S
Cell Immunol; 1992 Mar; 140(1):173-83. PubMed ID: 1371241
[TBL] [Abstract][Full Text] [Related]
18. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
Ceuppens JL; Van Vaeck F
Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to common epitopes of the human alpha/beta T-cell receptor preferentially activate CD45RA+ T-cells.
Schwinzer R; Schlitt HJ; Wonigeit K
Cell Immunol; 1992 Mar; 140(1):31-41. PubMed ID: 1531453
[TBL] [Abstract][Full Text] [Related]
20. T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.
Gebel HM; Lebeck LK; Jensik SC; Webster K; Bray RA
Hum Immunol; 1989 Oct; 26(2):123-9. PubMed ID: 2479623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
